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The endocannabinoid system (ECS) has a well-documented pivotal role in the control of mammalian reproductive functions,
by acting at multiple levels, that is, central (CNS) and local (gonads) levels. Since studies performed in animal models other
than mammals might provide further insight into the biology of these signalling molecules, in the present paper we review the
comparative data pointing toward the endocannabinoid involvement in the reproductive control of non-mammalian vertebrates,
focussing in particular on the central regulation of teleost and amphibian reproduction.Themorphofunctional distribution of brain
cannabinoid receptors will be discussed in relation to other crucial signalling molecules involved in the control of reproductive
functions, such as GnRH, dopamine, aromatase, and pituitary gonadotropins.
1. Introduction
The endocannabinoid system (ECS) comprises several com-
ponents, among which are specific seven transmembrane-
domain receptors (i.e., CB1 and CB2 cannabinoid receptors),
their exogenous (e.g.,Δ9-THC) and endogenous ligands (e.g.,
AEA and 2-AG), and a number of biosynthetic and degrada-
tive enzymes (for a review, see [1]). CB1/CB2 receptors are
present not only in mammals but also in almost all classes of
vertebrates and also in urochordates and cephalochordates,
but not in the nonchordate invertebrate phyla. However,
enzymes involved in the biosynthesis/inactivation of the
endocannabinoids occur throughout the animal kingdom
(see the reviews [2, 3]). The fact that the ECS has a rather
wide phylogenetic distribution points to a fundamental mod-
ulatory role of endocannabinoids in the control of central and
peripheral activities, for example, neurotransmission, neural
development, hormone release and action, appetite regu-
lation, immunomodulation, cardiovascular and respiratory
functions, bone formation, and notably reproduction (for a
review, see [4]). Indeed, in both humans and othermammals,
the potent negative effects of cannabinoids at peripheral
and central levels in embryo implantation, maintenance
of pregnancy, and hormonal regulation have been widely
documented [5, 6]. In addition, a role for the ECS in the
modulation of nonmammalian reproduction has come to
light in the last years (for a review, see [7]).
In the present work we will first review the data about
the morphofunctional distribution of the cannabinoid recep-
tors in the CNS of nonmammalian vertebrates, namely,
teleosts and amphibians. In the second part, we will present
comparative data about the involvement of the ECS in the
central regulation of reproductive activities of bony fish and
amphibians.
2. Functional Relevance of Cannabinoid
Receptors in Teleost and Amphibian CNS
After the first discovery of CB1 cannabinoid receptors in
mammals [8, 9], the cloning of two genes coding for the
CB1 receptor subtypes CB1A and CB1B in the bony fish
Fugu rubripes [10] represented a true milestone in the ECS
comparative investigations. Since then, duplicate copies of
either the CB1 or CB2 genes (CNR1, CNR2) or both have
been reported in several teleost species. In the puffer fish
Fugu rubripes, as alreadymentioned, two CB1 receptor genes,
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but only one CB2 gene, are present [10, 11], consistently with
the finding of two CB1 genes and one CB2 gene in another
puffer fish species, Tetraodon nigroviridis [2, 12]. On the other
hand, in the zebrafish Danio rerio, only one CB1 gene has
been detected [13], while two CB2 genes (CB2A and CB2B)
are present [14]. In the goldfish Carassius auratus, only one
CB1 and one CB2 sequences have been cloned so far [15–
17]. In the sole Solea solea, two CB1 (CB1A and CB1B) were
identified [18], while in Pelvicachromis pulcher [19], Sparus
aurata [20], and Apteronotus leptorhynchus [21] only one CB1
gene has been cloned.Thepresence of duplicate genes is a well
known phenomenon in teleosts [22] and can be ascribed to
a whole-genome duplication that occurred during evolution
of the ray-finned lineage before the teleost radiation. At least
three different events have been suggested to occur after gene
duplication: (1) one gene of the pair evolves as a pseudogene
through degenerative mutations and is eliminated because of
its dispensability (most frequent event); (2) duplicate genes
are preserved and remain functional; in this case, one copy
can acquire a mutation conferring a new and beneficial
function (neofunctionalization), whereas the other retains
the original function; (3) duplicate genes can be preserved
and share the multiple functions of the ancestral gene by
complementary loss of subfunctions. Thus far, the functional
significance of the differential retention of duplicate CB1 or
CB2 genes in different teleost lineages is mostly unknown.
In one report [14] the expression of CB2A and CB2B has
been compared by RT-PCR in various zebrafish tissues,
showing a similar distributionwith few exceptions (brain and
muscle, where CB2A was very low); however, no functional
conclusions can be drawn from this study. Recently Palermo
et al. [18] showed that in Solea solea in a stress paradigm
CB1B mRNA levels were significantly reduced in ovary
and brain of stressed fish, while CB1A mRNA remained
unchanged, suggesting a possible subfunctionalization of the
two duplicate genes.
For what concerns amphibians, CB1 cannabinoid recep-
tors have been cloned and characterized in the rough-skinned
newt Taricha granulosa [23], in the African clawed frog
Xenopus laevis [24] and in the green frog Rana esculenta
[25], while the presence of a CB2 gene has been revealed in
Xenopus tropicalis [2].
Since the distribution of a receptor could give information
on its physiological role, a number of studies have been
conducted to characterize the localization of cannabinoid
receptors.
2.1. Distribution of CB1/CB2 Cannabinoid Receptors in Teleost
CNS. Although the puffer fish was the first nonmammalian
species where CB1 receptors were identified, little is known
about cannabinoid receptor distribution in this species. The
few available data [10] outline, however, that CB1 receptors
are highly expressed in the brain and they are present at lower
levels in nonneural tissues, thus indicating an evolutionarily
conserved feature common to all vertebrates.
The first data on CB1 receptor distribution in the brain of
a teleost were obtained in the African cichlid Pelvicachromis
pulcher [16, 19]. By using immunohistochemical techniques,
abundant CB1-immunostainings were observed throughout
the telencephalon, in the preoptic area, lateral infundibular
lobes of the posterior hypothalamus and pituitary gland,
thus suggesting that cannabinoids affect neuroendocrine
mechanisms and might indeed be involved in the control
of reproduction. An intense CB1-immunoreactivity was also
detected in the pretectum and nucleus glomerulosus of the
posterior tuberculum, both transitional areas between pro-
and mesencephalon, that are involved in the integration of
visual-motor activities in order to orient fish toward preys
and elicit appetite [26–28]. In the dorsal mesencephalic
tegmentum, some large intensely CB1-immunopositive nerve
cells, possibly motor neurons of the III cranial nerve, were
observed. In the cerebellum, few granule cells and Purkinje
cells were stained, as well as a number of 𝛼-motoneurons in
the spinal cord.
A study in the goldfish [15] showed that CB1-immuno-
reactivities are distributed through all the forebrain, includ-
ing the olfactory bulbs. Abundant immunostainings were
observed in the inferior lobes of the posterior hypothalamus
surrounding the third ventricle lateral recesses; these brain
areas are involved in bony fish feeding response, thus provid-
ing morphological evidence for the reported involvement of
the endocannabinoid system in the goldfish appetite control.
The same CB1-immunopositive brain regions are also pivotal
for the control of teleost reproduction, the involvement
of the ECS being also supported by the finding of CB1-
immunopositive fibres in the goldfish infundibulum, but not
in the pituitary (Cottone, unpublished data), contrary to
what was observed in Pelvicachromis pulcher, where pituitary
CB1-immunopositive cells were instead observed [29]. In the
goldfish, a number of CB1 immunostained cell bodies were
also detected in the telencephalon immediately below the
ventricular ependyma and were identified as radial glial cells
[29, 30]; these cells are very abundant in adult fish, probably
due to the absence of astrocytes and ependymal cells and
do serve mostly as neural progenitors and newborn neuron
migrating scaffolds, as well as neurosteroid-producing cells.
The expression of cannabinoid receptors in goldfish radial
glial cells does therefore suggest an ECS regulation of neuro-
genesis in fish, according to what occurred in mammals (for
a review [31]).
In zebrafish, CB1 distribution was analysed both in larvae
and adult brains, by means of in situ hybridization (ISH)
[13]. An early CB1 mRNA expression was detected in the
preoptic area of the hypothalamus and, later, within the dor-
sal telencephalon and mesodiencephalon. In postembryonic
larvae and adult brain CB1 mRNA is primarily expressed
in the dorsal telencephalon, synencephalon, torus longitu-
dinalis, and periventricular hypothalamus, thus suggesting
the involvement of the ECS in cognitive processes and
neurogenesis.
Very recently, Harvey-Girard et al. [21] presented data on
CB1 receptor distribution in the brain of the weakly electric
fish Apteronotus leptorhynchus. Accordingly with what was
observed in the other teleosts, CB1mRNA is expressedmainly
in the telencephalon (especially in subpallial neurons and
dorsocentral telencephalon) and in fewer cells in the rest
of the brain. CB1 distribution seems to reflect a possible
role in the regulation of the electrosensory system and
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electrocommunication that are particularly developed and
important in gymnotiform fish.
Since CB2 receptor genes have been identified in non-
mammalian vertebrates more recently than CB1, data about
their distribution are scarce. For instance, Rodriguez-Martin
et al. [14] have shown in zebrafish by ISH that CB2 mRNA is
expressed in the rostral and proximal pars distalis of the pitu-
itary gland, while expression in the brain was only detected
by RT-PCR. In goldfish CB2 mRNA has been detected in
the brain, although at levels much lower than CB1 mRNA
[17] and the immunostaining of goldfish forebrain sections
did actually reveal the presence of CB2-immunopositive cells
that were identified as radial glial cells, that is, adult neural
progenitors [30].
2.2. Distribution of CB1/CB2 Cannabinoid Receptors in
Amphibian CNS. The first report on the occurrence of the
ECS in the amphibian CNS concerned the pharmacological
and molecular characterization of CB1 receptors in the
urodele amphibian Taricha granulosa [23]. In this same
species, ISH experiments showed CB1 mRNA expression in
the telencephalon, in particular in the olfactory bulb, pallium,
bed nucleus of the stria terminalis and nucleus amygdalae
dorsolateralis; CB1 mRNA is also expressed in regions of the
preoptic area, thalamus, midbrain tegmentum and tectum,
cerebellum, and the stratum griseum of the hindbrain [32].
The distribution of CB1 receptor has been also investi-
gated in the CNS of adults and embryos/larvae of the anuran
amphibian Xenopus laevis. In particular, in whole embryos of
Xenopus laevis CB1 mRNA was first detected at stage 28, and
from stage 41 it appears in the rhombencephalon and there-
after also in the olfactory placodes and then in the olfactory
bulbs [33]. In adult Xenopus laevis, CB1-immunostainings
and CB1 mRNA-positive cells were detected in the olfactory
bulb, dorsal and medial pallium, striatum and amygdala,
thalamus and hypothalamus, mesencephalic tegmentum,
cerebellum and spinal cord [24, 34, 35]. Moreover, CB1
receptors were detected in lactotrophs, gonadotrophs, and
thyrotrophs of the pituitary gland [36].
In the green frog Rana esculenta CB1 immunostained
neurons and nerve fibres are abundant in the telencephalic
hemispheres, preoptic area, hypothalamus, and a number of
hindbrain areas [37, 38]. Interestingly, fluctuations during
the annual sexual cycle of CB1 mRNA expression in various
regions of the brain, as well as at the testicular level, have
been reported and a possible involvement of the ECS in the
regulation of gonadal activity has been postulated [38, 39].
On the basis of their neuroanatomical distribution and
relationships with a number of other signalling molecules
[34, 35], the amphibian CB1 cannabinoid receptors have been
mainly considered modulators in sensory and sensorimotor
integrations and endocrine and behavioral outputs. More-
over, since the intense CB1 mRNA ISH staining found in
Taricha granulosa amigdaloid complex [32] well matched
the strong CB1-immunoreactivity and mRNA expression in
the corresponding nucleus of Xenopus laevis [24, 34], the
endocannabinoid-mediated modulation of fear, anxiety, and
stress responses has also been postulated.
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Figure 1: Schematic representation of the hypothalamus-pituitary-
gonadal (HPG) axis.
3. The Endocannabinoid System Is Involved
in the Central Regulation of Teleost and
Amphibian Reproductive Functions
The reproductive functions are regulated by the neuroen-
docrine system, so that a tight crosstalk between the hypotha-
lamus, pituitary, and gonads takes place (Figure 1). In particu-
lar, the decapeptide GnRH is released from the hypothalamus
and stimulates pituitary to release gonadotropins. FSH and
LH act then at the gonadal levels, regulating spermatogenesis,
oocyte growth, and steroidogenesis.
Cannabinoids exert potent negative effects upon both
experimental animal and human reproduction, affecting
gonadotropin synthesis and release, gonadic steroid produc-
tion, spermatogenesis, ovulation, embryo development and
implantation, sexual behaviour [6, 40, 41]. In vertebrates
ECS modulates reproductive functions by acting at multiple
levels (for a review, see [42]). Centrally, ECS negatively
affects the secretion of pituitary gonadotropin hormones,
by acting at the hypothalamic level. Also, a direct action
on pituitary is possible, since AEA regulates in vitro pitu-
itary hormone secretions in rat [43], and CB1 receptor has
been found in mammalian pituitary anterior lobe [44] and
in Xenopus laevis PRL and FSH cells [36]. The fact that
CB1 receptors were detected in the Leydig cells of mouse
testis and the endogenous cannabinoid anandamide (AEA)
suppressed testosterone secretion by testes in normal but
not in CB1 knockout mice [43] was the first evidence that
cannabinoids do modulate reproductive functions also at
the peripheral level. Recent data also point out a role for
CB2 receptor, whose presence was observed in rat and
human ovaries [45, 46], in human oocytes [47] and mouse
spermatogonia [48]. In addition, endocannabinoids control
sperm motility and/or acrosomic reaction [49–53], as well
as ovulation, implantation, embryonic development, foetal
growth, lactation (see the reviews [6, 54]). It is noteworthy
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Figure 2: Schematic representation of direct and indirect effects of
the ECS in the control of GnRH release (from [57]).
that also in nonmammalian vertebrates basic components of
the endocannabinoid system were found and characterized
both in the brain and in the gonads. CB1 mRNA expression
was in fact detected in the gonads of Carassius auratus and
Pelvicachromis pulcher [55] and Sparus aurata [20] andDanio
rerio [56], as well asXenopus laevis [55]. InRana esculenta the
occurrence of both CB1 receptors and FAAH in the gonads
was reported and CB1 levels have been shown to fluctuate
during the annual sexual cycle [53], consistently with the
observations in the brain [38, 39]. Also, the ECS inhibits male
courtship clasping behaviour in the newt Taricha granulosa
[23] and interferes with mammalian copulatory behaviour
[6]. At the moment there are scarce or no available data
regardingCB2 receptor in nonmammalian vertebrate gonads,
with the exception of the teleost goldfish, where CB2 mRNA
was found in testis and ovary [17].
At the central level, the action of the ECS on the
hypothalamus has been first demonstrated by the observa-
tion that both exogenous and endogenous cannabinoids are
responsible for the decrease of circulating LH and sexual
steroids, by acting through a CB1-mediated inhibition of
GnRH-I (formerly called mammalianGnRH) discharge (for
a review, see [57]). The cannabinoid ligands might inhibit
GnRH secreting neurons by activating specific signalling
circuitries (e.g., GABA, dopamine, CRF, opioid) and inhibit-
ing others (e.g., glutamate, norepinephrine). Moreover, since
immortalized hypothalamic GnRH neurons are capable of
releasing endogenous cannabinoids such as AEA and 2-
AG and do possess CB1 and CB2 receptors [58], a direct
neural control of GnRH-I release has been postulated (see
Figure 2). Since GnRH is a key molecule in the gonadotropic
regulation of all vertebrates, studies on themorphofunctional
relationships between ECS andGnRHwere conducted also in
nonmammalian vertebrates. In particular, in Pelvicachromis
pulcher, Carassius auratus, Solea solea, and Danio rerio, a
close contiguity between CB1-immunostainings and GnRH-
III- (previously called salmonGnRH) immununoreactive cell
bodies and nerve fibers was observed in brain areas that are
pivotal for the control of reproduction, such as the basal
telencephalon, the preoptic area, and the hypothalamus ([16,
55, 59] and Cottone, unpublished data). Consistently, in Rana
esculenta and Xenopus laevis, the codistribution of CB1- and
GnRH-I-immunoreactivity occurred in brain areas corre-
sponding to those described in the above teleost species [37,
55]. In particular, a subset of frog GnRH-I-immunoreactive
neurons in the septum and preoptic area, together with
nerve fibres and terminals in the median eminence of
the neurohypophysis, were found CB1-immunopositive [38].
Interestingly, during the frog annual sexual cycle, GnRH-I
mRNAandCB1 levels have opposite expression profiles in the
telencephalon and diencephalon [38, 60]. Also, anandamide
is able to inhibit GnRH-I and GnRH-II synthesis and to
affectGnRH receptors expression in the diencephalon, aswell
as in the testis; at the same time, a GnRH agonist inhibits
the synthesis of GnRH-I mRNA and induces an increase
in CB1 transcription [38, 61, 62], thus suggesting reciprocal
relationships between the ECS and the GnRH system.
In line with dopaminergic control of fish reproduction
through inhibition of both PRL release and gonadotropin
(GTH-I andGTH-II) synthesis [63], CB1-immunoreactivities
were found codistributed with TH- (the dopamine biosyn-
thetic rate-limiting enzyme) immunopositive neurons and
fibres in the basal telencephalon/preoptic area of Pelvi-
cachromis pulcher and Carassius auratus [16]. Also, in the
diencephalic paraventricular organ (PVO) of the goldfish a
number of CB1-immunopositive cerebrospinal fluid (CSF)
contacting neurons were found closely adjacent to the TH-
positive neurons that innervate the neurointermediate and
the distal lobes of the teleost pituitary, thus indicating a
CB1-mediated control of PVO dopaminergic neurons and,
consequently, a direct or indirect regulation of pituitary
activity [29].
Another molecule deeply involved in the reproductive
physiology is aromatase (estrogen synthase), the enzyme that
catalyzes the transformation of androgens into estrogens (for
a review, see [64]). Aromatase is expressed both in gonads
and brain; brain aromatase is essential for testosterone-
mediated regulation of physiological and behavioural pro-
cesses, such as sexual differentiation of the brain, activation
of male sexual behaviour, and regulation of gonadotropic
hormone secretion, as well as neurogenesis. Teleost fish do
possess two aromatase genes, codifying for aromatase A,
that is specifically expressed in the gonads, and aromatase
B, that is strongly expressed in the brain. Indeed, teleosts,
compared to other vertebrates, show remarkably high levels
of brain aromatase activity and protein and gene expression,
due to an autoregulatory loop through which estrogens
and aromatizable androgens upregulate aromatase expression
[65]. In zebrafish abundant aromatase-positive cells have
been observed in the olfactory bulbs, telencephalon, preoptic
area, and the hypothalamus, as well as in the thalamus,
optic tectum, and around the fourth ventricle [66–68]. Inter-
estingly, brain aromatase expression and activity fluctuate
seasonally and with the reproductive state. Peculiarly, in
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Figure 3: Aromatase/CB1 immunoreactivities in the goldfish lateral recesses of the hypothalamus (depicted in the schematic draw of
the goldfish brain, lateral view). (a), (b) and (c), (d): consecutive coronal sections showing in (a) and (c) a large number of aromatase-
immunopositive radial glial cell processes codistributed with ((b) and (d), resp.) abundant CB1-immunopositive fibers and cell processes.
Calibration bars: 100𝜇m. Cereb: cerebellum; hyp: hypothalamus; rhomb: rhombencephalon; tect: optic tectum of the mesencephalon; tel:
telencephalon; vagal lobe: lobe of the X cranial nerve.
teleosts brain aromatase is not expressed by neurons, as seen
in mammals and birds. Instead, it is specifically expressed by
radial glial cells [66], the cells that sustain the highneurogenic
activity of adult fish; thus, in fish, aromatase is likely to be the
key molecule enabling brain growth and brain sexualization
throughout life. Given the role of aromatase in reproductive
physiology, we evaluated the possible existence of a crosstalk
between the ECS and brain aromatase, by analyzing the
codistribution of CB1 cannabinoid receptors and aromatase
in brain sections of both zebrafish and goldfish. In the
preoptic area and periventricular grey of the hypothalamic
inferior lobes, a tight contiguity between the twomarkers was
indeed found (Figure 3 and data not shown), thus suggesting
a CB1-mediated regulation of aromatase activity at least in
bony fish.
4. Concluding Remarks
The data reported in teleosts and amphibians strongly sup-
port the modulatory role of brain ECS on several neural cir-
cuits, including those involved in the control of reproductive
functions.
Although the general physiological role of endocannabi-
noids is far from being understood in nonmammalian verte-
brates, the investigations in organisms different from mam-
mals might provide new insights into the cannabinoid biol-
ogy. Basic information on the ECS derived from comparative
investigations in invertebrates and/or anamniote vertebrates,
besides bearing value for evolutionary and wildlife biological
studies, could contribute to a better understanding of the
mechanisms of action of cannabinoid-related molecules and
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stimulate the development of new strategies for their thera-
peutic use in humans.
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